FIS vs ORMP
Fidelity National Information Services Inc (FIS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported FIS revenue for 2024-12-31 was $2.60B. Net income was $282.0M. Revenue was up 1.1% from 2024-09-30 to 2024-12-31. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
FIS currently screens at market cap $21.12B and trailing P/E 7.9. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the FIS and ORMP stock pages for the full models.
Not investment advice.